Skip to main content

Table 1 Anthropometric and clinical characteristics

From: Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type

   (Range)
Race (MA/C/AA) 22/11/3  
Age (y) 55 ± 2 (32–70)
Duration of Diabetes 6 ± 1 (1–16)
Diet/SU therapy 20/16  
Body Weight (kg) 89 ± 3 (60–119)
Height (cm) 172 ± 1 (156–192)
Body Mass Index (kg/m2) 30 ± 1 (22.9–38.9)
Body Surface Area (m2) 2.05 ± 0.03 (1.61–2.52)
Fat Mass (kg) 31 ± 2 (13.6–51.5)
Fasting Plasma Glucose (mg/dl) 199 ± 7 (101–265)
Fasting Plasma Insulin (μU/ml) 15 ± 1 (5.5–39.1)
HbA1c (%) 9.0 ± 0.2 (6.8–11.9)
Fasting Free Fatty Acid (μEq/L) 589 ± 22 (320–921)
Basal EGP (mg/kg FFM·min) 3.0 ± 0.1 (1.74–4.64)
Clamp EGP (mg/kg FFM·min) 1.2 ± 0.1 (0.2–2.2)
TGD (mg/kg FFM·min) 3.5 ± 0.2 (1.6–7.7)
SSPI 67 ± 2 (44–84)
Clamp EGP × SSPI 76 ± 7 (10–156)
TGD/SSPI 0.05 ± 0.003 (0.02–0.10)
Clamp FFA (μEq/L) 230 ± 13 (118–389)
VF (cm2) 159 ± 9 (75–337)
SF (cm2) 303 ± 21 (108–651)
VF/SF Ratio 0.59 ± 0.04 (0.17–1.30)
Deep SF (cm2) 199 ± 14 (53–418)
Superficial SF (cm2) 104 ± 8 (44–232)
  1. MA = Mexican American; C = Caucasian; AA = African American
  2. FFM = fat free mass (kg)
  3. EGP = endogenous glucose production rate
  4. Clamp EGP = endogenous glucose production rate during insulin clamp
  5. SSPI = steady state plasma insulin concentration during insulin clamp
  6. Clamp FFA = plasma free fatty acid concentration during insulin clamp
  7. TGD = total glucose disposal rate during insulin clamp
  8. Clamp EGP × SSPI = product of the Clamp EGP and steady state plasma insulin concentration during insulin clamp (index of hepatic insulin resistance)
  9. TGD/SSPI = TGD divided by SSPI (index of peripheral [muscle] insulin sensitivity)
  10. VF = visceral fat area at L4–5
  11. SF = subcutaneous fat area at L4–5
\